Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3 Pt 1
|
pubmed:dateCreated |
1990-4-12
|
pubmed:abstractText |
Preoperative chemotherapy with CDDP, MMC, UFT and etoposide (PMUE) was performed on cases of far advanced gastric cancer whose curative resection was impossible. The therapy comprised 1-5 courses of either intravenous or arterial infusion, or intraperitoneal administration of CDDP 75 mg/m2, MMC 10 mg/body and Etoposide 50 X 3 mg/body at 3-week intervals in combined use of UFT 400 mg/body. The effect of the preoperative PMUE therapy was CR, PR, NC and PD in 0, 7, 1 and 0 cases, respectively, the rate of effectiveness being 88% (7/8). 5 of 7 cases with PR were operated on, 2 cases succeeded in curative resection, but 3 cases did not. Histological judgment of effects confirmed Grade II-a, II-b and III in 2, 2 and 1 cases, respectively; these 5 cases further received 1-4 courses of PMUE therapy as postoperative adjuvant chemotherapy and are still alive at P.S. 0-2, suggesting the great efficacy of this PMUE therapy as a neoadjuvant chemotherapy for improvement in prognosis in far advanced gastric cancer. Abnormally high values of the tumor marker were noted in 5 of 8 cases, 4 of which had tumor marker values lowered in exponential function by the preoperative chemotherapy, which constituted an effective index in determining chemotherapeutic effects and the determination of the operative timing.
|
pubmed:language |
jpn
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin,
http://linkedlifedata.com/resource/pubmed/chemical/Etoposide,
http://linkedlifedata.com/resource/pubmed/chemical/Mitomycin,
http://linkedlifedata.com/resource/pubmed/chemical/Mitomycins,
http://linkedlifedata.com/resource/pubmed/chemical/Tegafur,
http://linkedlifedata.com/resource/pubmed/chemical/Uracil
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0385-0684
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
391-6
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:2106835-Adult,
pubmed-meshheading:2106835-Aged,
pubmed-meshheading:2106835-Aged, 80 and over,
pubmed-meshheading:2106835-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:2106835-Cisplatin,
pubmed-meshheading:2106835-Combined Modality Therapy,
pubmed-meshheading:2106835-Drug Administration Schedule,
pubmed-meshheading:2106835-Etoposide,
pubmed-meshheading:2106835-Female,
pubmed-meshheading:2106835-Humans,
pubmed-meshheading:2106835-Male,
pubmed-meshheading:2106835-Middle Aged,
pubmed-meshheading:2106835-Mitomycin,
pubmed-meshheading:2106835-Mitomycins,
pubmed-meshheading:2106835-Preoperative Care,
pubmed-meshheading:2106835-Prognosis,
pubmed-meshheading:2106835-Stomach Neoplasms,
pubmed-meshheading:2106835-Tegafur,
pubmed-meshheading:2106835-Uracil
|
pubmed:year |
1990
|
pubmed:articleTitle |
[Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide].
|
pubmed:affiliation |
Dept. of Surgery, National Sanatorium Tsuruga Hospital.
|
pubmed:publicationType |
Journal Article,
English Abstract
|